Literature DB >> 690187

Decreased pulmonary transvascular fluid filtration in awake newborn lambs after intravenous furosemide.

R D Bland, D D McMillan, M A Bressack.   

Abstract

We studied the effect of furosemide on pulmonary transvascular filtration of fluid and microvascular permeability to plasma proteins by measuring steady-state lung lymph flow and protein flow, pulmonary arterial and left atrial pressures in nine 1-wk-old unanesthetized lambs before and after rapid intravenous infusion of furosemide, 1 mg/kg in 10 experiments and 8 mg/kg in 5 experiments. With rapid diuresis induced by furosemide (an eightfold increase in urine flow), lung vascular pressures decreased, protein concentrations of lymph and plasma increased, and there was a consistent decrease in lymph flow and lymph protein flow, more pronounced after the larger dose. Five additional lambs received 8 mg/kg of furosemide intravenously in the presence of saline-induced pulmonary edema; in these experiments, the decrease in vascular pressures, increase in transvascular protein gradient, and decrease in lymph flow were greater than in lambs without pulmonary edema. These findings suggest that furosemide decreases transvascular filtration of fluid in the lung by diminishing the transvascular hydraulic pressure gradient and increasing the transvascular gradient for protein osmotic pressure. In five acute experiments on anesthetized lambs with kidneys removed, 8 mg/kg of intravenous furosemide decreased lymph flow one-half as much as it did in the presence of kidneys, with no change in lung vascular pressures or protein concentrations. The results of experiments in lambs without kidneys are consistent with a reduction in the vascular surface area for exchange of fluid and protein in the lung.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 690187      PMCID: PMC371805          DOI: 10.1172/JCI109166

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  A quantitative radioautographic comparison of albumin concentration in different dized lymph vessels in normal mouse lungs.

Authors:  G Nicolaysen; A Nicolaysen; N C Staub
Journal:  Microvasc Res       Date:  1975-09       Impact factor: 3.514

2.  The early effects of intravenous frusemide on central haemodynamics, venous tone and plasma renin activity.

Authors:  B Hesse; I Nielsen; H Lund-Jacobsen
Journal:  Clin Sci Mol Med       Date:  1975-12

3.  Preparation of chronic lung lymph fistulas in sheep.

Authors:  N C Staub; R D Bland; K L Brigham; R Demling; A J Erdmann; W C Woolverton
Journal:  J Surg Res       Date:  1975-11       Impact factor: 2.192

4.  Lung fluid dynamics in awake newborn lambs.

Authors:  R D Bland; D D McMillan
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

5.  Acute hemodynamic effects of furosemide administered intravenously in the horse.

Authors:  W W Muir; D W Milne; R T Skarda
Journal:  Am J Vet Res       Date:  1976-10       Impact factor: 1.156

6.  The role of the kidney in the early nondiuretic action of furosemide to reduce elevated left atrial pressure in the hypervolemic dog.

Authors:  W A Bourland; D K Day; H E Williamson
Journal:  J Pharmacol Exp Ther       Date:  1977-07       Impact factor: 4.030

7.  Lung lymph and free interstitial fluid protein composition in sheep with edema.

Authors:  C R Vreim; P D Snashall; R H Demling; N C Staub
Journal:  Am J Physiol       Date:  1976-06

8.  Effect of furosemide on renal hilar lymph flow.

Authors:  N T Stowe; J B Hook
Journal:  Arch Int Pharmacodyn Ther       Date:  1976-12

9.  Effect of increased vascular pressure on lung fluid balance in unanesthetized sheep.

Authors:  A J Erdmann; T R Vaughan; K L Brigham; W C Woolverton; N C Staub
Journal:  Circ Res       Date:  1975-09       Impact factor: 17.367

10.  The acute hemodynamic effects of ethacrynic acid and furosemide in patients with chronic postcapillary pulmonary hypertension.

Authors:  S M Austin; B F Schreiner; D H Kramer; P M Shah; P N Yu
Journal:  Circulation       Date:  1976-02       Impact factor: 29.690

View more
  8 in total

Review 1.  Diuretics for respiratory distress syndrome in preterm infants.

Authors:  Audra Stewart; Luc P Brion; Roger Soll
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 2.  Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.

Authors:  Audra Stewart; Luc P Brion
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

3.  Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study.

Authors:  Carol J Blaisdell; James Troendle; Anne Zajicek
Journal:  J Pediatr       Date:  2018-03-26       Impact factor: 4.406

Review 4.  Interventions for the management of transient tachypnoea of the newborn - an overview of systematic reviews.

Authors:  Matteo Bruschettini; Karl-Omar Hassan; Olga Romantsik; Rita Banzi; Maria Grazia Calevo; Luca Moresco
Journal:  Cochrane Database Syst Rev       Date:  2022-02-24

5.  Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia.

Authors:  Jonathan L Slaughter; Michael R Stenger; Patricia B Reagan
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

6.  Effect of furosemide in canine low-pressure pulmonary edema.

Authors:  J Ali; W Chernicki; L D Wood
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

7.  Fluid restriction in the management of transient tachypnea of the newborn.

Authors:  Neeraj Gupta; Matteo Bruschettini; Deepak Chawla
Journal:  Cochrane Database Syst Rev       Date:  2021-02-18

8.  Loop Diuretics in Severe Bronchopulmonary Dysplasia: Cumulative Use and Associations with Mortality and Age at Discharge.

Authors:  Nicolas A Bamat; Timothy D Nelin; Eric C Eichenwald; Haresh Kirpalani; Matthew M Laughon; Wesley M Jackson; Erik A Jensen; Kathleen A Gibbs; Scott A Lorch
Journal:  J Pediatr       Date:  2020-11-03       Impact factor: 4.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.